{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:06:58Z","timestamp":1789538818250,"version":"build-2803163510"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>A subset of uterine leiomyomas becomes clinically apparent during pregnancy\/delivery and is typically excised during Cesarean section. Although benign, these leiomyomas excised during pregnancy and\/or delivery (LEPs) can pose diagnostic challenges due to morphologic changes that mimic malignant mesenchymal neoplasms, such as leiomyosarcoma. This study analyzed 97 LEPs to characterize their histopathologic and immunohistochemical features. Histologic examination revealed predominantly low mitotic activity (mean: 0.5 mitoses\/10\u00a0HPFs) and mild (87.6% of tumors) to at most focal moderate (9.3% of tumors) nuclear atypia. Ischemic necrosis occurred in 57.7% of tumors. Features attributed to coagulative necrosis were common, including sharp viable-nonviable transition (22.7%), perivascular tumor preservation (9.3%), and ghost outlines of tumor cell nuclei (50.5%). Focal myxoid changes, affecting \u226430% of tumor volume, were seen in 42.3% of tumors. Rare, bizarre cells were identified in 48.5% of tumors. Immunohistochemistry demonstrated the absence of estrogen receptor staining in 65% of tumors, with focal staining in 35.2%, and progesterone receptor expression in 97.7%. Caldesmon (98.9%) and desmin (100%) were positive, with the majority diffuse. CD10 (100%) showed variable staining intensity. Wild-type p53 expression was seen in all tumors tested. Expression of ATRX, MTAP, RB1, and PTEN was predominantly retained with equivocal staining in 35.3% (ATRX) and 3.4% (RB1) of tumors. Although Cyclin D1 expression was common (97.4%), it was always focal, with no diffuse (\u226570%) strong nuclear staining. FH loss occurred in 3.2% of tumors. All tumors were negative for MelanA, and 92.4% were negative for HMB45. Calretinin expression was observed in 39% of tumors, typically focal and strong, while only 1 tumor showed positive inhibin staining in &lt;5% of cells. ALK expression was focally positive or equivocal in 9.6% of cases, but no gene rearrangements were identified by in situ hybridization. Follow-up data were available for 71 patients (mean: 56\u00a0mo), with no malignant transformation or recurrence. These findings confirm that LEPs exhibit distinct morphologic and immunophenotypic alterations, including features typically attributed to coagulative tumor cell necrosis. However, given benign clinical outcomes, low mitotic activity, and lack of significant atypia, such a finding does not warrant designation as leiomyosarcoma or smooth muscle tumor of uncertain malignant potential in the context of concurrent pregnancy.<\/jats:p>","DOI":"10.1097\/pas.0000000000002589","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:02:57Z","timestamp":1784095377000},"page":"1240-1251","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Uterine Leiomyomas Presenting During Pregnancy and Delivery"],"prefix":"10.1097","volume":"50","author":[{"given":"Ekaterina","family":"Olkhov-Mitsel","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Division of Anatomic Pathology, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Amemiya","sequence":"additional","affiliation":[{"name":"Genomics Core Facility, Sunnybrook Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Seth","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Division of Anatomic Pathology, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Center"},{"name":"Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Parra-Herran","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Mirkovic","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Division of Anatomic Pathology, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Center"},{"name":"Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Carlos Parra-Herran and Jelena Mirkovic are co-senior authors"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmu048","article-title":"Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications","volume":"21","author":"Moravek","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.fertnstert.2007.06.044","article-title":"Uterine myomas: management","volume":"88","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environ Health Perspect"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum Reprod"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0039-128X(00)00171-9","article-title":"Effects of progesterone on uterine leiomyoma growth and apoptosis","volume":"65","author":"Maruo","year":"2000","journal-title":"Steroids"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jcp.2011.089664","article-title":"Unusual morphological features of uterine leiomyomas treated with progestogens","volume":"64","author":"Boyd","year":"2011","journal-title":"J Clin Pathol"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/uog.8826","article-title":"Uterine myomas during pregnancy: a longitudinal sonographic study","volume":"37","author":"De Vivo","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12905-019-0803-5","article-title":"Growth pattern of uterine leiomyoma along pregnancy","volume":"19","author":"Chill","year":"2019","journal-title":"BMC Womens Health"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01606522","article-title":"Immunohistochemical analysis of estrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy","volume":"419","author":"Kawaguchi","year":"1991","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PGP.0000000000000969","article-title":"\u201cDeciduoid\u201d change in uterine leiomyomas in pregnancy: aberrant expression of sex cord markers, inhibin and calretinin","volume":"43","author":"Machuca-Aguado","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.prp.2011.09.001","article-title":"Pathological characteristics and clinical outcome of uterine leiomyomas associated with pregnancy","volume":"207","author":"Muezzinoglu","year":"2011","journal-title":"Pathol Res Pract"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/modpathol.2015.139","article-title":"Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia","volume":"29 Suppl 1","author":"Oliva","year":"2016","journal-title":"Mod Pathol"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/PGP.0000000000000323","article-title":"ALK-rearranged inflammatory myofibroblastic tumor of the placenta, with observations on site of origin","volume":"36","author":"Schoolmeester","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1148\/radiographics.19.suppl_1.g99oc04s131","article-title":"Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds","volume":"19","author":"Ueda","year":"1999","journal-title":"Radiographics"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/PAS.0000000000000569","article-title":"Apoplectic leiomyomas: a morphologic analysis of 100 cases highlighting unusual features","volume":"40","author":"Bennett","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2463\/mrms.mp.2018-0074","article-title":"Evaluation of red degeneration of uterine leiomyoma with susceptibility-weighted MR imaging","volume":"18","author":"Takeuchi","year":"2019","journal-title":"Magn Reson Med Sci"},{"key":"R20-20260916","first-page":"267","article-title":"Pathologic features of soft tissue fibrosarcoma with special reference to the grading of its malignancy","volume":"69","author":"Broders","year":"1939","journal-title":"Surg Gynecol Obste"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41379-022-01011-z","article-title":"A novel morphology-based risk stratification model for stage I uterine leiomyosarcoma: an analysis of 203 cases","volume":"35","author":"Chapel","year":"2022","journal-title":"Mod Pathol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAS.0000000000001795","article-title":"Epithelioid leiomyosarcoma of the uterus: modern outcome-based appraisal of diagnostic criteria in a large institutional series","volume":"46","author":"Chapel","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/PAS.0000000000000249","article-title":"Uterine leiomyomas with bizarre nuclei: a clinicopathologic study of 59 cases","volume":"38","author":"Croce","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/cancers17081327","article-title":"Inflammatory myofibroblastic tumor: an updated review","volume":"17","author":"Choi","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N Engl J Med"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3390\/cancers12082126","article-title":"Genomic database analysis of uterine leiomyosarcoma mutational profile","volume":"12","author":"Astolfi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1055\/a-1533-1651","article-title":"Risk of recurrence in uterine leiomyoma with bizarre nuclei: a systematic review and meta-analysis","volume":"81","author":"Travaglino","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/PAS.0b013e3182851162","article-title":"Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma","volume":"37","author":"Lim","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.fertnstert.2003.08.043","article-title":"Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors","volume":"81","author":"Bodner","year":"2004","journal-title":"Fertil Steril"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9378(84)90428-9","article-title":"Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy","volume":"150","author":"Khan-Dawood","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.1994.tb21732.x","article-title":"Decidual progesterone and estrogen receptors in the first trimester of pregnancy","volume":"734","author":"Noci","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"100084","DOI":"10.1016\/j.modpat.2022.100084","article-title":"Molecular-based immunohistochemical algorithm for uterine leiomyosarcoma diagnosis","volume":"36","author":"Momeni-Boroujeni","year":"2023","journal-title":"Mod Pathol"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"154335","DOI":"10.1016\/j.prp.2023.154335","article-title":"Uterine inflammatory myofibroblastic tumor","volume":"242","author":"Karpathiou","year":"2023","journal-title":"Pathol Res Pract"},{"key":"R36-20260916","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.1016\/j.gore.2021.100852","article-title":"Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy","volume":"37","author":"Kyi","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"R37-20260916","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/PGP.0000000000000704","article-title":"ALK immunohistochemistry and molecular analysis in uterine inflammatory myofibroblastic tumor: proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting","volume":"40","author":"Parra-Herran","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R38-20260916","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","article-title":"Fumarase-deficient uterine leiomyomas: an Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases","volume":"40","author":"Miettinen","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R39-20260916","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41379-020-0596-y","article-title":"Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants","volume":"33","author":"Popp","year":"2020","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:00:23Z","timestamp":1789538423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002589"}},"subtitle":["Comprehensive Characterization of Features Helpful in the Distinction From Malignant Mimics"],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002589","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"2025-11-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}